Սուր միելոյիդ լեյկեմիա (Armenian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Սուր միելոյիդ լեյկեմիա" in Armenian language version.

refsWebsite

Global rank Armenian rank

57nih.gov

4^th place

3^rd place

44doi.org

2^nd place

4^th place

21semanticscholar.org

11^th place

428^th place

12archive.org

6^th place

4worldcat.org

5^th place

10^th place

2books.google.com

3^rd place

17^th place

2web.archive.org

1^st place

2google.se

2,848^th place

3,385^th place

2cancer.gov

1,684^th place

184^th place

1ascp.org

low place

1medscape.com

719^th place

149^th place

1pathologyoutlines.com

low place

3,591^st place

1oncodaily.com

low place

1prnewswire.com

406^th place

1,926^th place

1hematologylibrary.org

low place

3,008^th place

1cancerresearchuk.org

8,489^th place

1,817^th place

1zenodo.org

621^st place

1,041^st place

1harvard.edu

18^th place

38^th place

archive.org

Yoshinaga S, Mabuchi K, Sigurdson AJ, Doody MM, Ron E (2004 թ․ նոյեմբեր). «Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies». Radiology. 233 (2): 313–321. doi:10.1148/radiol.2332031119. PMID 15375227. S2CID 20643232.
Greer JP, Foerster J, Lukens JN, Rogers GM, Paraskevas F, Glader BE, eds. (2004). Wintrobe's Clinical Hematology (11th ed.). Philadelphia: Lippincott, Williams, and Wilkins. էջեր 2045–2062. ISBN 978-0-7817-3650-3.
Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, և այլք: (2017). WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. International Agency for Research on Cancer. էջ 25. ISBN 978-92-832-4494-3.
Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, և այլք: (1996 թ․ սեպտեմբեր). «Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party». British Journal of Haematology. 94 (3): 557–573. doi:10.1046/j.1365-2141.1996.d01-1004.x. PMID 8790159. S2CID 8271000.
Bloomfield CD, Brunning RD (1985 թ․ սեպտեմբեր). «FAB M7: acute megakaryoblastic leukemia--beyond morphology». Annals of Internal Medicine. 103 (3): 450–452. doi:10.7326/0003-4819-103-3-450. PMID 4040724.
Unless otherwise specified in boxes, reference is: Page 97 in: Sun T (2008). Flow cytometry and immunohistochemistry for hematologic neoplasms. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0-7817-8400-9. OCLC 85862340.
Page 99 in: Sun T (2009). Atlas of hematologic neoplasms. Dordrecht New York: Springer. ISBN 978-0-387-89848-3. OCLC 432709321.
Matthews JP, Bishop JF, Young GA, Juneja SK, Lowenthal RM, Garson OM, և այլք: (2001 թ․ հունիս). «Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia». British Journal of Haematology. 113 (3): 727–736. doi:10.1046/j.1365-2141.2001.02756.x. PMID 11380464. S2CID 34233226.
Wheatley K, Burnett AK, Goldstone AH, Gray RG, Hann IM, Harrison CJ, և այլք: (1999 թ․ հոկտեմբեր). «A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties». British Journal of Haematology. 107 (1): 69–79. doi:10.1046/j.1365-2141.1999.01684.x. PMID 10520026. S2CID 27266593.
Jameson JL, Kasper DL, Fauci AS, Hauser SL, Longo DL, Loscalzo J (2018). Harrison's Principles of Internal Medicine (20 ed.). McGraw-Hill Professional. ISBN 9781259644030.
Hoffman R (2005). Hematology: Basic Principles and Practice (4th ed.). St. Louis, Mo.: Elsevier Churchill Livingstone. էջեր 1071. ISBN 978-0-443-06629-0.
Virchow R (1856). «Die Leukämie». In Virchow R (ed.). Gesammelte Abhandlungen zur Wissenschaftlichen Medizin (գերմաներեն). Frankfurt: Meidinger. էջ 190.

ascp.org

Foucar K. «Bone Marrow Pathology» (PDF) (3rd ed.). ASCP. Արխիվացված է օրիգինալից (PDF) 2013 թ․ մարտի 19-ին. Վերցված է 2016 թ․ մարտի 18-ին.

books.google.com

Bain BJ (2015). Blood Cells: A Practical Guide (5 ed.). John Wiley & Sons. էջ 432. ISBN 978-1-118-81733-9.
Greer JP, Arber DA, Glader BE, List AF, Means RM, Rodgers GM (2018). «Chapter 74: Diagnosis and Classification of the Acute Leukemias and Myelodysplastic Syndromes». Wintrobe's Clinical Hematology (14th ed.). Wolters Kluwer Health. ISBN 978-1-4963-6713-6.

cancer.gov

«Adult Acute Myeloid Leukemia Treatment». National Cancer Institute. 2017 թ․ մարտի 6. Վերցված է 2017 թ․ դեկտեմբերի 19-ին.

seer.cancer.gov

«Acute Myeloid Leukemia – Cancer Stat Facts». NCI. Վերցված է 2017 թ․ մայիսի 10-ին.

cancerresearchuk.org

«Acute myeloid leukaemia (AML) statistics». Cancer Research UK. 2015 թ․ մայիսի 14. Վերցված է 2022 թ․ ապրիլի 3-ին.

doi.org

Döhner H, Weisdorf DJ, Bloomfield CD (2015 թ․ սեպտեմբեր). «Acute Myeloid Leukemia». The New England Journal of Medicine. 373 (12): 1136–1152. doi:10.1056/NEJMra1406184. PMID 26376137. S2CID 40314260.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, և այլք: (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (2016 թ․ հոկտեմբեր). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, և այլք: (GBD 2015 Mortality and Causes of Death Collaborators) (2016 թ․ հոկտեմբեր). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, և այլք: (2016 թ․ մարտ). «Acute myeloid leukaemia». Nature Reviews. Disease Primers. 2 (1): 16010. doi:10.1038/nrdp.2016.10. PMID 27159408. S2CID 4028327.
Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM (2019 թ․ հուլիս). «Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges». Blood Reviews. 36: 70–87. doi:10.1016/j.blre.2019.04.005. PMID 31101526. S2CID 155630692.
Sanz GF, Sanz MA, Vallespí T, Cañizo MC, Torrabadella M, García S, և այլք: (1989 թ․ հուլիս). «Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients». Blood. 74 (1): 395–408. doi:10.1182/blood.V74.1.395.395. PMID 2752119.
Radivoyevitch T, Sachs RK, Gale RP, Molenaar RJ, Brenner DJ, Hill BT, և այլք: (2016 թ․ փետրվար). «Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation». Leukemia. 30 (2): 285–294. doi:10.1038/leu.2015.258. PMID 26460209. S2CID 22100511.
Bizzozero OJ, Johnson KG, Ciocco A (1966 թ․ մայիս). «Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964. I. Distribution, incidence and appearance time». The New England Journal of Medicine. 274 (20): 1095–1101. doi:10.1056/NEJM196605192742001. PMID 5932020.
Yoshinaga S, Mabuchi K, Sigurdson AJ, Doody MM, Ron E (2004 թ․ նոյեմբեր). «Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies». Radiology. 233 (2): 313–321. doi:10.1148/radiol.2332031119. PMID 15375227. S2CID 20643232.
Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJ, Bleeker FE (2014 թ․ դեկտեմբեր). «The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation». Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846 (2): 326–341. doi:10.1016/j.bbcan.2014.05.004. PMID 24880135.
Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Przychodzen B, և այլք: (2015 թ․ նոյեմբեր). «Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms». Leukemia. 29 (11): 2134–2142. doi:10.1038/leu.2015.91. PMC 5821256. PMID 25836588.
Sharma S, Kelly TK, Jones PA (2010 թ․ հունվար). «Epigenetics in cancer». Carcinogenesis. 31 (1): 27–36. doi:10.1093/carcin/bgp220. PMC 2802667. PMID 19752007.
Baldus CD, Mrózek K, Marcucci G, Bloomfield CD (2007 թ․ հունիս). «Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review». British Journal of Haematology. 137 (5): 387–400. doi:10.1111/j.1365-2141.2007.06566.x. PMID 17488484. S2CID 30419482.
Vardiman JW, Harris NL, Brunning RD (2002 թ․ հոկտեմբեր). «The World Health Organization (WHO) classification of the myeloid neoplasms». Blood. 100 (7): 2292–2302. doi:10.1182/blood-2002-04-1199. PMID 12239137. S2CID 9413654.
Amin HM, Yang Y, Shen Y, Estey EH, Giles FJ, Pierce SA, և այլք: (2005 թ․ սեպտեմբեր). «Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias». Leukemia. 19 (9): 1567–1572. doi:10.1038/sj.leu.2403876. PMID 16049515.
Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, և այլք: (1996 թ․ սեպտեմբեր). «Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party». British Journal of Haematology. 94 (3): 557–573. doi:10.1046/j.1365-2141.1996.d01-1004.x. PMID 8790159. S2CID 8271000.
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, և այլք: (2016 թ․ մայիս). «The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia». Blood. 127 (20): 2391–2405. doi:10.1182/blood-2016-03-643544. PMID 27069254. S2CID 18338178.
Molica M, Perrone S (2022 թ․ նոյեմբեր). «Molecular targets for the treatment of AML in the forthcoming 5th World Health Organization Classification of Haematolymphoid Tumours». Expert Review of Hematology. 15 (11): 973–986. doi:10.1080/17474086.2022.2140137. PMID 36271671. S2CID 253063457.
Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, և այլք: (2022 թ․ հուլիս). «The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms». Leukemia. 36 (7): 1703–1719. doi:10.1038/s41375-022-01613-1. PMC 9252913. PMID 35732831.
Estey EH (2018 թ․ հոկտեմբեր). «Acute myeloid leukemia: 2019 update on risk-stratification and management». American Journal of Hematology. 93 (10): 1267–1291. doi:10.1002/ajh.25214. PMID 30328165. S2CID 53523035.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976 թ․ օգոստոս). «Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group». British Journal of Haematology. 33 (4): 451–458. doi:10.1111/j.1365-2141.1976.tb03563.x. PMID 188440. S2CID 9985915.
Bloomfield CD, Brunning RD (1985 թ․ սեպտեմբեր). «FAB M7: acute megakaryoblastic leukemia--beyond morphology». Annals of Internal Medicine. 103 (3): 450–452. doi:10.7326/0003-4819-103-3-450. PMID 4040724.
Lee EJ, Pollak A, Leavitt RD, Testa JR, Schiffer CA (1987 թ․ նոյեմբեր). «Minimally differentiated acute nonlymphocytic leukemia: a distinct entity». Blood. 70 (5): 1400–1406. doi:10.1182/blood.v70.5.1400.bloodjournal7051400. PMID 3663939.
Salem DA, Abd El-Aziz SM (2012 թ․ հունիս). «Flowcytometric immunophenotypic profile of acute leukemia: mansoura experience». Indian Journal of Hematology & Blood Transfusion. 28 (2): 89–96. doi:10.1007/s12288-011-0110-2. PMC 3332273. PMID 23730015.
Partial expression: Adriaansen HJ, te Boekhorst PA, Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen JJ (1993 թ․ հունիս). «Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression». Blood. 81 (11): 3043–3051. doi:10.1182/blood.V81.11.3043.bloodjournal81113043. PMID 8098967.
Duchayne E, Demur C, Rubie H, Robert A, Dastugue N (1999 թ․ հունվար). «Diagnosis of acute basophilic leukemia». Leukemia & Lymphoma. 32 (3–4): 269–278. doi:10.3109/10428199909167387. PMID 10037024.
Kayser S, Levis MJ (2014 թ․ փետրվար). «FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations». Leukemia & Lymphoma. 55 (2): 243–255. doi:10.3109/10428194.2013.800198. PMC 4333682. PMID 23631653.
Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, և այլք: (2017 թ․ հունվար). «Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel». Blood. 129 (4): 424–447. doi:10.1182/blood-2016-08-733196. PMC 5291965. PMID 27895058.
Küley-Bagheri Y, Kreuzer KA, Monsef I, Lübbert M, Skoetz N, և այլք: (Cochrane Haematological Malignancies Group) (2018 թ․ օգոստոս). «Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL))». The Cochrane Database of Systematic Reviews. 2018 (8): CD011960. doi:10.1002/14651858.CD011960.pub2. PMC 6513628. PMID 30080246.
Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, և այլք: (2010 թ․ հունվար). «Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet». Blood. 115 (3): 453–474. doi:10.1182/blood-2009-07-235358. PMID 19880497. S2CID 1088077.
Knips L, Bergenthal N, Streckmann F, Monsef I, Elter T, Skoetz N, և այլք: (Cochrane Haematological Malignancies Group) (2019 թ․ հունվար). «Aerobic physical exercise for adult patients with haematological malignancies». The Cochrane Database of Systematic Reviews. 1 (1): CD009075. doi:10.1002/14651858.CD009075.pub3. PMC 6354325. PMID 30702150.
Ali S, Jones GL, Culligan DJ, Marsden PJ, Russell N, Embleton ND, Craddock C (2015 թ․ օգոստոս). «Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy». British Journal of Haematology. 170 (4): 487–495. doi:10.1111/bjh.13554. PMID 26081614. S2CID 11298224.
Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, և այլք: (1998 թ․ դեկտեմբեր). «Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission». The New England Journal of Medicine. 339 (23): 1649–1656. doi:10.1056/NEJM199812033392301. PMID 9834301.
Matthews JP, Bishop JF, Young GA, Juneja SK, Lowenthal RM, Garson OM, և այլք: (2001 թ․ հունիս). «Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia». British Journal of Haematology. 113 (3): 727–736. doi:10.1046/j.1365-2141.2001.02756.x. PMID 11380464. S2CID 34233226.
Wheatley K, Burnett AK, Goldstone AH, Gray RG, Hann IM, Harrison CJ, և այլք: (1999 թ․ հոկտեմբեր). «A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties». British Journal of Haematology. 107 (1): 69–79. doi:10.1046/j.1365-2141.1999.01684.x. PMID 10520026. S2CID 27266593.
Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, և այլք: (2000 թ․ դեկտեմբեր). «Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study». Blood. 96 (13): 4075–4083. doi:10.1182/blood.V96.13.4075. PMID 11110676.
Byrd JC, Mrózek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, և այլք: (2002 թ․ դեկտեմբեր). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood. 100 (13): 4325–4336. doi:10.1182/blood-2002-03-0772. PMID 12393746. S2CID 16003833.
Haferlach T, Schoch C, Löffler H, Gassmann W, Kern W, Schnittger S, և այլք: (2003 թ․ հունվար). «Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies». Journal of Clinical Oncology. 21 (2): 256–265. doi:10.1200/JCO.2003.08.005. PMID 12525517.
Jemal A, Thomas A, Murray T, Thun M (2002). «Cancer statistics, 2002». CA. 52 (1): 23–47. doi:10.3322/canjclin.52.1.23. PMID 11814064. S2CID 5659023.
Strickland SA, Vey N (2022 թ․ մարտ). «Diagnosis and treatment of therapy-related acute myeloid leukemia». Critical Reviews in Oncology/Hematology. 171: 103607. doi:10.1016/j.critrevonc.2022.103607. PMID 35101585. S2CID 246443548.
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001). «Cancer statistics, 2001». CA. 51 (1): 15–36. doi:10.3322/canjclin.51.1.15. PMID 11577478. S2CID 22441565.
Wang ZY (2003). «Ham-Wasserman lecture: treatment of acute leukemia by inducing differentiation and apoptosis». Hematology. American Society of Hematology. Education Program. 2003 (1): 1–13. doi:10.1182/asheducation-2003.1.1. PMID 14633774. S2CID 2788589.
Naegeli O (1900). «Über rothes Knochenmark und Myeloblasten». Deutsche Medizinische Wochenschrift. 26 (18): 287–290. doi:10.1055/s-0029-1203820.
Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, և այլք: (2008 թ․ նոյեմբեր). «DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome». Nature. 456 (7218): 66–72. Bibcode:2008Natur.456...66L. doi:10.1038/nature07485. PMC 2603574. PMID 18987736.

google.se

books.google.se

Unless otherwise specified in boxes, reference is: Page 97 in: Sun T (2008). Flow cytometry and immunohistochemistry for hematologic neoplasms. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0-7817-8400-9. OCLC 85862340.
Page 99 in: Sun T (2009). Atlas of hematologic neoplasms. Dordrecht New York: Springer. ISBN 978-0-387-89848-3. OCLC 432709321.

harvard.edu

ui.adsabs.harvard.edu

Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, և այլք: (2008 թ․ նոյեմբեր). «DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome». Nature. 456 (7218): 66–72. Bibcode:2008Natur.456...66L. doi:10.1038/nature07485. PMC 2603574. PMID 18987736.

hematologylibrary.org

bloodjournal.hematologylibrary.org

Sanz MA, Lo Coco F, Martín G, Avvisati G, Rayón C, Barbui T, և այլք: (2000 թ․ օգոստոս). «Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups». Blood. 96 (4): 1247–1253. PMID 10942364. Արխիվացված է օրիգինալից 2010 թ․ մայիսի 27-ին. Վերցված է 2008 թ․ մարտի 17-ին.

medscape.com

emedicine.medscape.com

Seiter K, Jules EH (2011 թ․ մայիսի 20). «Acute Myeloid Leukemia Staging». Վերցված է 2011 թ․ օգոստոսի 26-ին.

nih.gov

pubmed.ncbi.nlm.nih.gov

Döhner H, Weisdorf DJ, Bloomfield CD (2015 թ․ սեպտեմբեր). «Acute Myeloid Leukemia». The New England Journal of Medicine. 373 (12): 1136–1152. doi:10.1056/NEJMra1406184. PMID 26376137. S2CID 40314260.
Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, և այլք: (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (2016 թ․ հոկտեմբեր). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, և այլք: (GBD 2015 Mortality and Causes of Death Collaborators) (2016 թ․ հոկտեմբեր). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, և այլք: (2016 թ․ մարտ). «Acute myeloid leukaemia». Nature Reviews. Disease Primers. 2 (1): 16010. doi:10.1038/nrdp.2016.10. PMID 27159408. S2CID 4028327.
Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM (2019 թ․ հուլիս). «Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges». Blood Reviews. 36: 70–87. doi:10.1016/j.blre.2019.04.005. PMID 31101526. S2CID 155630692.
Sanz GF, Sanz MA, Vallespí T, Cañizo MC, Torrabadella M, García S, և այլք: (1989 թ․ հուլիս). «Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients». Blood. 74 (1): 395–408. doi:10.1182/blood.V74.1.395.395. PMID 2752119.
Radivoyevitch T, Sachs RK, Gale RP, Molenaar RJ, Brenner DJ, Hill BT, և այլք: (2016 թ․ փետրվար). «Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation». Leukemia. 30 (2): 285–294. doi:10.1038/leu.2015.258. PMID 26460209. S2CID 22100511.
Bizzozero OJ, Johnson KG, Ciocco A (1966 թ․ մայիս). «Radiation-related leukemia in Hiroshima and Nagasaki, 1946-1964. I. Distribution, incidence and appearance time». The New England Journal of Medicine. 274 (20): 1095–1101. doi:10.1056/NEJM196605192742001. PMID 5932020.
Yoshinaga S, Mabuchi K, Sigurdson AJ, Doody MM, Ron E (2004 թ․ նոյեմբեր). «Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies». Radiology. 233 (2): 313–321. doi:10.1148/radiol.2332031119. PMID 15375227. S2CID 20643232.
Molenaar RJ, Radivoyevitch T, Maciejewski JP, van Noorden CJ, Bleeker FE (2014 թ․ դեկտեմբեր). «The driver and passenger effects of isocitrate dehydrogenase 1 and 2 mutations in oncogenesis and survival prolongation». Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846 (2): 326–341. doi:10.1016/j.bbcan.2014.05.004. PMID 24880135.
Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Przychodzen B, և այլք: (2015 թ․ նոյեմբեր). «Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms». Leukemia. 29 (11): 2134–2142. doi:10.1038/leu.2015.91. PMC 5821256. PMID 25836588.
Sharma S, Kelly TK, Jones PA (2010 թ․ հունվար). «Epigenetics in cancer». Carcinogenesis. 31 (1): 27–36. doi:10.1093/carcin/bgp220. PMC 2802667. PMID 19752007.
Baldus CD, Mrózek K, Marcucci G, Bloomfield CD (2007 թ․ հունիս). «Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review». British Journal of Haematology. 137 (5): 387–400. doi:10.1111/j.1365-2141.2007.06566.x. PMID 17488484. S2CID 30419482.
Vardiman JW, Harris NL, Brunning RD (2002 թ․ հոկտեմբեր). «The World Health Organization (WHO) classification of the myeloid neoplasms». Blood. 100 (7): 2292–2302. doi:10.1182/blood-2002-04-1199. PMID 12239137. S2CID 9413654.
Amin HM, Yang Y, Shen Y, Estey EH, Giles FJ, Pierce SA, և այլք: (2005 թ․ սեպտեմբեր). «Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias». Leukemia. 19 (9): 1567–1572. doi:10.1038/sj.leu.2403876. PMID 16049515.
Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, և այլք: (1996 թ․ սեպտեմբեր). «Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party». British Journal of Haematology. 94 (3): 557–573. doi:10.1046/j.1365-2141.1996.d01-1004.x. PMID 8790159. S2CID 8271000.
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, և այլք: (2016 թ․ մայիս). «The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia». Blood. 127 (20): 2391–2405. doi:10.1182/blood-2016-03-643544. PMID 27069254. S2CID 18338178.
Molica M, Perrone S (2022 թ․ նոյեմբեր). «Molecular targets for the treatment of AML in the forthcoming 5th World Health Organization Classification of Haematolymphoid Tumours». Expert Review of Hematology. 15 (11): 973–986. doi:10.1080/17474086.2022.2140137. PMID 36271671. S2CID 253063457.
Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, և այլք: (2022 թ․ հուլիս). «The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms». Leukemia. 36 (7): 1703–1719. doi:10.1038/s41375-022-01613-1. PMC 9252913. PMID 35732831.
Estey EH (2018 թ․ հոկտեմբեր). «Acute myeloid leukemia: 2019 update on risk-stratification and management». American Journal of Hematology. 93 (10): 1267–1291. doi:10.1002/ajh.25214. PMID 30328165. S2CID 53523035.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976 թ․ օգոստոս). «Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group». British Journal of Haematology. 33 (4): 451–458. doi:10.1111/j.1365-2141.1976.tb03563.x. PMID 188440. S2CID 9985915.
Bloomfield CD, Brunning RD (1985 թ․ սեպտեմբեր). «FAB M7: acute megakaryoblastic leukemia--beyond morphology». Annals of Internal Medicine. 103 (3): 450–452. doi:10.7326/0003-4819-103-3-450. PMID 4040724.
Lee EJ, Pollak A, Leavitt RD, Testa JR, Schiffer CA (1987 թ․ նոյեմբեր). «Minimally differentiated acute nonlymphocytic leukemia: a distinct entity». Blood. 70 (5): 1400–1406. doi:10.1182/blood.v70.5.1400.bloodjournal7051400. PMID 3663939.
Salem DA, Abd El-Aziz SM (2012 թ․ հունիս). «Flowcytometric immunophenotypic profile of acute leukemia: mansoura experience». Indian Journal of Hematology & Blood Transfusion. 28 (2): 89–96. doi:10.1007/s12288-011-0110-2. PMC 3332273. PMID 23730015.
Partial expression: Adriaansen HJ, te Boekhorst PA, Hagemeijer AM, van der Schoot CE, Delwel HR, van Dongen JJ (1993 թ․ հունիս). «Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression». Blood. 81 (11): 3043–3051. doi:10.1182/blood.V81.11.3043.bloodjournal81113043. PMID 8098967.
Duchayne E, Demur C, Rubie H, Robert A, Dastugue N (1999 թ․ հունվար). «Diagnosis of acute basophilic leukemia». Leukemia & Lymphoma. 32 (3–4): 269–278. doi:10.3109/10428199909167387. PMID 10037024.
Kayser S, Levis MJ (2014 թ․ փետրվար). «FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations». Leukemia & Lymphoma. 55 (2): 243–255. doi:10.3109/10428194.2013.800198. PMC 4333682. PMID 23631653.
Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, և այլք: (2017 թ․ հունվար). «Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel». Blood. 129 (4): 424–447. doi:10.1182/blood-2016-08-733196. PMC 5291965. PMID 27895058.
Küley-Bagheri Y, Kreuzer KA, Monsef I, Lübbert M, Skoetz N, և այլք: (Cochrane Haematological Malignancies Group) (2018 թ․ օգոստոս). «Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL))». The Cochrane Database of Systematic Reviews. 2018 (8): CD011960. doi:10.1002/14651858.CD011960.pub2. PMC 6513628. PMID 30080246.
Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, և այլք: (2010 թ․ հունվար). «Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet». Blood. 115 (3): 453–474. doi:10.1182/blood-2009-07-235358. PMID 19880497. S2CID 1088077.
Knips L, Bergenthal N, Streckmann F, Monsef I, Elter T, Skoetz N, և այլք: (Cochrane Haematological Malignancies Group) (2019 թ․ հունվար). «Aerobic physical exercise for adult patients with haematological malignancies». The Cochrane Database of Systematic Reviews. 1 (1): CD009075. doi:10.1002/14651858.CD009075.pub3. PMC 6354325. PMID 30702150.
Verma S, Dhanda H, Singh A, Rishi B, Tanwar P, Chaudhry S, և այլք: (2021 թ․ հոկտեմբեր). «Systematic review of epigenetic targets in acute myeloid leukemia». American Journal of Blood Research. 11 (5): 458–471. PMC 8610793. PMID 34824880.
Ali S, Jones GL, Culligan DJ, Marsden PJ, Russell N, Embleton ND, Craddock C (2015 թ․ օգոստոս). «Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy». British Journal of Haematology. 170 (4): 487–495. doi:10.1111/bjh.13554. PMID 26081614. S2CID 11298224.
Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, և այլք: (1998 թ․ դեկտեմբեր). «Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission». The New England Journal of Medicine. 339 (23): 1649–1656. doi:10.1056/NEJM199812033392301. PMID 9834301.
Matthews JP, Bishop JF, Young GA, Juneja SK, Lowenthal RM, Garson OM, և այլք: (2001 թ․ հունիս). «Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia». British Journal of Haematology. 113 (3): 727–736. doi:10.1046/j.1365-2141.2001.02756.x. PMID 11380464. S2CID 34233226.
Sanz MA, Lo Coco F, Martín G, Avvisati G, Rayón C, Barbui T, և այլք: (2000 թ․ օգոստոս). «Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups». Blood. 96 (4): 1247–1253. PMID 10942364. Արխիվացված է օրիգինալից 2010 թ․ մայիսի 27-ին. Վերցված է 2008 թ․ մարտի 17-ին.
Wheatley K, Burnett AK, Goldstone AH, Gray RG, Hann IM, Harrison CJ, և այլք: (1999 թ․ հոկտեմբեր). «A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties». British Journal of Haematology. 107 (1): 69–79. doi:10.1046/j.1365-2141.1999.01684.x. PMID 10520026. S2CID 27266593.
Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, և այլք: (2000 թ․ դեկտեմբեր). «Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study». Blood. 96 (13): 4075–4083. doi:10.1182/blood.V96.13.4075. PMID 11110676.
Byrd JC, Mrózek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, և այլք: (2002 թ․ դեկտեմբեր). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood. 100 (13): 4325–4336. doi:10.1182/blood-2002-03-0772. PMID 12393746. S2CID 16003833.
Haferlach T, Schoch C, Löffler H, Gassmann W, Kern W, Schnittger S, և այլք: (2003 թ․ հունվար). «Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies». Journal of Clinical Oncology. 21 (2): 256–265. doi:10.1200/JCO.2003.08.005. PMID 12525517.
Jemal A, Thomas A, Murray T, Thun M (2002). «Cancer statistics, 2002». CA. 52 (1): 23–47. doi:10.3322/canjclin.52.1.23. PMID 11814064. S2CID 5659023.
Strickland SA, Vey N (2022 թ․ մարտ). «Diagnosis and treatment of therapy-related acute myeloid leukemia». Critical Reviews in Oncology/Hematology. 171: 103607. doi:10.1016/j.critrevonc.2022.103607. PMID 35101585. S2CID 246443548.
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001). «Cancer statistics, 2001». CA. 51 (1): 15–36. doi:10.3322/canjclin.51.1.15. PMID 11577478. S2CID 22441565.
Wang ZY (2003). «Ham-Wasserman lecture: treatment of acute leukemia by inducing differentiation and apoptosis». Hematology. American Society of Hematology. Education Program. 2003 (1): 1–13. doi:10.1182/asheducation-2003.1.1. PMID 14633774. S2CID 2788589.
Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, և այլք: (2008 թ․ նոյեմբեր). «DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome». Nature. 456 (7218): 66–72. Bibcode:2008Natur.456...66L. doi:10.1038/nature07485. PMC 2603574. PMID 18987736.

ncbi.nlm.nih.gov

Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, և այլք: (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (2016 թ․ հոկտեմբեր). «Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.
Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, և այլք: (GBD 2015 Mortality and Causes of Death Collaborators) (2016 թ․ հոկտեմբեր). «Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015». Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
Molenaar RJ, Thota S, Nagata Y, Patel B, Clemente M, Przychodzen B, և այլք: (2015 թ․ նոյեմբեր). «Clinical and biological implications of ancestral and non-ancestral IDH1 and IDH2 mutations in myeloid neoplasms». Leukemia. 29 (11): 2134–2142. doi:10.1038/leu.2015.91. PMC 5821256. PMID 25836588.
Sharma S, Kelly TK, Jones PA (2010 թ․ հունվար). «Epigenetics in cancer». Carcinogenesis. 31 (1): 27–36. doi:10.1093/carcin/bgp220. PMC 2802667. PMID 19752007.
Khoury JD, Solary E, Abla O, Akkari Y, Alaggio R, Apperley JF, և այլք: (2022 թ․ հուլիս). «The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms». Leukemia. 36 (7): 1703–1719. doi:10.1038/s41375-022-01613-1. PMC 9252913. PMID 35732831.
Salem DA, Abd El-Aziz SM (2012 թ․ հունիս). «Flowcytometric immunophenotypic profile of acute leukemia: mansoura experience». Indian Journal of Hematology & Blood Transfusion. 28 (2): 89–96. doi:10.1007/s12288-011-0110-2. PMC 3332273. PMID 23730015.
Kayser S, Levis MJ (2014 թ․ փետրվար). «FLT3 tyrosine kinase inhibitors in acute myeloid leukemia: clinical implications and limitations». Leukemia & Lymphoma. 55 (2): 243–255. doi:10.3109/10428194.2013.800198. PMC 4333682. PMID 23631653.
Döhner H, Estey E, Grimwade D, Amadori S, Appelbaum FR, Büchner T, և այլք: (2017 թ․ հունվար). «Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel». Blood. 129 (4): 424–447. doi:10.1182/blood-2016-08-733196. PMC 5291965. PMID 27895058.
Küley-Bagheri Y, Kreuzer KA, Monsef I, Lübbert M, Skoetz N, և այլք: (Cochrane Haematological Malignancies Group) (2018 թ․ օգոստոս). «Effects of all-trans retinoic acid (ATRA) in addition to chemotherapy for adults with acute myeloid leukaemia (AML) (non-acute promyelocytic leukaemia (non-APL))». The Cochrane Database of Systematic Reviews. 2018 (8): CD011960. doi:10.1002/14651858.CD011960.pub2. PMC 6513628. PMID 30080246.
Knips L, Bergenthal N, Streckmann F, Monsef I, Elter T, Skoetz N, և այլք: (Cochrane Haematological Malignancies Group) (2019 թ․ հունվար). «Aerobic physical exercise for adult patients with haematological malignancies». The Cochrane Database of Systematic Reviews. 1 (1): CD009075. doi:10.1002/14651858.CD009075.pub3. PMC 6354325. PMID 30702150.
Verma S, Dhanda H, Singh A, Rishi B, Tanwar P, Chaudhry S, և այլք: (2021 թ․ հոկտեմբեր). «Systematic review of epigenetic targets in acute myeloid leukemia». American Journal of Blood Research. 11 (5): 458–471. PMC 8610793. PMID 34824880.
Ley TJ, Mardis ER, Ding L, Fulton B, McLellan MD, Chen K, և այլք: (2008 թ․ նոյեմբեր). «DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome». Nature. 456 (7218): 66–72. Bibcode:2008Natur.456...66L. doi:10.1038/nature07485. PMC 2603574. PMID 18987736.

oncodaily.com

Inc, P53 (2024 թ․ մայիսի 24). «Acute Myeloid Leukemia: What patients should know about - OncoDaily». oncodaily.com (ամերիկյան անգլերեն). Վերցված է 2024 թ․ հունիսի 24-ին. {{cite web}}: |last= has generic name (օգնություն)CS1 սպաս․ թվային անուններ: authors list (link)

pathologyoutlines.com

Mihova D. «Leukemia acute – Acute myeloid leukemia with minimal differentiation (FAB AML M0)». Pathology Outlines. Topic Completed: 1 March 2013. Minor changes: 19 November 2019

prnewswire.com

«Rigel Announces U.S. FDA Approval of Rezlidhia (olutasidenib) for the Treatment of Adult Patients with Relapsed or Refractory Acute Myeloid Leukemia with a Susceptible IDH1 Mutation» (Press release). Rigel Pharmaceuticals. 2022 թ․ դեկտեմբերի 1. Վերցված է 2022 թ․ դեկտեմբերի 2-ին – via PR Newswire.

semanticscholar.org

api.semanticscholar.org

Döhner H, Weisdorf DJ, Bloomfield CD (2015 թ․ սեպտեմբեր). «Acute Myeloid Leukemia». The New England Journal of Medicine. 373 (12): 1136–1152. doi:10.1056/NEJMra1406184. PMID 26376137. S2CID 40314260.
Khwaja A, Bjorkholm M, Gale RE, Levine RL, Jordan CT, Ehninger G, և այլք: (2016 թ․ մարտ). «Acute myeloid leukaemia». Nature Reviews. Disease Primers. 2 (1): 16010. doi:10.1038/nrdp.2016.10. PMID 27159408. S2CID 4028327.
Shallis RM, Wang R, Davidoff A, Ma X, Zeidan AM (2019 թ․ հուլիս). «Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges». Blood Reviews. 36: 70–87. doi:10.1016/j.blre.2019.04.005. PMID 31101526. S2CID 155630692.
Radivoyevitch T, Sachs RK, Gale RP, Molenaar RJ, Brenner DJ, Hill BT, և այլք: (2016 թ․ փետրվար). «Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation». Leukemia. 30 (2): 285–294. doi:10.1038/leu.2015.258. PMID 26460209. S2CID 22100511.
Yoshinaga S, Mabuchi K, Sigurdson AJ, Doody MM, Ron E (2004 թ․ նոյեմբեր). «Cancer risks among radiologists and radiologic technologists: review of epidemiologic studies». Radiology. 233 (2): 313–321. doi:10.1148/radiol.2332031119. PMID 15375227. S2CID 20643232.
Baldus CD, Mrózek K, Marcucci G, Bloomfield CD (2007 թ․ հունիս). «Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review». British Journal of Haematology. 137 (5): 387–400. doi:10.1111/j.1365-2141.2007.06566.x. PMID 17488484. S2CID 30419482.
Vardiman JW, Harris NL, Brunning RD (2002 թ․ հոկտեմբեր). «The World Health Organization (WHO) classification of the myeloid neoplasms». Blood. 100 (7): 2292–2302. doi:10.1182/blood-2002-04-1199. PMID 12239137. S2CID 9413654.
Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, և այլք: (1996 թ․ սեպտեմբեր). «Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party». British Journal of Haematology. 94 (3): 557–573. doi:10.1046/j.1365-2141.1996.d01-1004.x. PMID 8790159. S2CID 8271000.
Arber DA, Orazi A, Hasserjian R, Thiele J, Borowitz MJ, Le Beau MM, և այլք: (2016 թ․ մայիս). «The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia». Blood. 127 (20): 2391–2405. doi:10.1182/blood-2016-03-643544. PMID 27069254. S2CID 18338178.
Molica M, Perrone S (2022 թ․ նոյեմբեր). «Molecular targets for the treatment of AML in the forthcoming 5th World Health Organization Classification of Haematolymphoid Tumours». Expert Review of Hematology. 15 (11): 973–986. doi:10.1080/17474086.2022.2140137. PMID 36271671. S2CID 253063457.
Estey EH (2018 թ․ հոկտեմբեր). «Acute myeloid leukemia: 2019 update on risk-stratification and management». American Journal of Hematology. 93 (10): 1267–1291. doi:10.1002/ajh.25214. PMID 30328165. S2CID 53523035.
Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, Sultan C (1976 թ․ օգոստոս). «Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group». British Journal of Haematology. 33 (4): 451–458. doi:10.1111/j.1365-2141.1976.tb03563.x. PMID 188440. S2CID 9985915.
Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, և այլք: (2010 թ․ հունվար). «Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet». Blood. 115 (3): 453–474. doi:10.1182/blood-2009-07-235358. PMID 19880497. S2CID 1088077.
Ali S, Jones GL, Culligan DJ, Marsden PJ, Russell N, Embleton ND, Craddock C (2015 թ․ օգոստոս). «Guidelines for the diagnosis and management of acute myeloid leukaemia in pregnancy». British Journal of Haematology. 170 (4): 487–495. doi:10.1111/bjh.13554. PMID 26081614. S2CID 11298224.
Matthews JP, Bishop JF, Young GA, Juneja SK, Lowenthal RM, Garson OM, և այլք: (2001 թ․ հունիս). «Patterns of failure with increasing intensification of induction chemotherapy for acute myeloid leukaemia». British Journal of Haematology. 113 (3): 727–736. doi:10.1046/j.1365-2141.2001.02756.x. PMID 11380464. S2CID 34233226.
Wheatley K, Burnett AK, Goldstone AH, Gray RG, Hann IM, Harrison CJ, և այլք: (1999 թ․ հոկտեմբեր). «A simple, robust, validated and highly predictive index for the determination of risk-directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial. United Kingdom Medical Research Council's Adult and Childhood Leukaemia Working Parties». British Journal of Haematology. 107 (1): 69–79. doi:10.1046/j.1365-2141.1999.01684.x. PMID 10520026. S2CID 27266593.
Byrd JC, Mrózek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC, և այլք: (2002 թ․ դեկտեմբեր). «Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)». Blood. 100 (13): 4325–4336. doi:10.1182/blood-2002-03-0772. PMID 12393746. S2CID 16003833.
Jemal A, Thomas A, Murray T, Thun M (2002). «Cancer statistics, 2002». CA. 52 (1): 23–47. doi:10.3322/canjclin.52.1.23. PMID 11814064. S2CID 5659023.
Strickland SA, Vey N (2022 թ․ մարտ). «Diagnosis and treatment of therapy-related acute myeloid leukemia». Critical Reviews in Oncology/Hematology. 171: 103607. doi:10.1016/j.critrevonc.2022.103607. PMID 35101585. S2CID 246443548.
Greenlee RT, Hill-Harmon MB, Murray T, Thun M (2001). «Cancer statistics, 2001». CA. 51 (1): 15–36. doi:10.3322/canjclin.51.1.15. PMID 11577478. S2CID 22441565.
Wang ZY (2003). «Ham-Wasserman lecture: treatment of acute leukemia by inducing differentiation and apoptosis». Hematology. American Society of Hematology. Education Program. 2003 (1): 1–13. doi:10.1182/asheducation-2003.1.1. PMID 14633774. S2CID 2788589.

web.archive.org

Foucar K. «Bone Marrow Pathology» (PDF) (3rd ed.). ASCP. Արխիվացված է օրիգինալից (PDF) 2013 թ․ մարտի 19-ին. Վերցված է 2016 թ․ մարտի 18-ին.
Sanz MA, Lo Coco F, Martín G, Avvisati G, Rayón C, Barbui T, և այլք: (2000 թ․ օգոստոս). «Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups». Blood. 96 (4): 1247–1253. PMID 10942364. Արխիվացված է օրիգինալից 2010 թ․ մայիսի 27-ին. Վերցված է 2008 թ․ մարտի 17-ին.

worldcat.org

Hoffbrand AV, Moss PA (2016). «13. Acute myeloid leukaemia». Hoffbrand's essential haematology (Seventh ed.). Chichester, West Sussex. էջեր 148–149. ISBN 978-1-118-40867-4. OCLC 909538759.{{cite book}}: CS1 սպաս․ location missing publisher (link)
Kaushansky K, Lichtman MA, Prchal JT, Levi M, Burns LJ, Linch DC, eds. (2021). «Acute myelogenous leukaemia». Williams hematology (Tenth ed.). New York: McGraw Hill. ISBN 978-1-260-46413-9. OCLC 1176325543.
Unless otherwise specified in boxes, reference is: Page 97 in: Sun T (2008). Flow cytometry and immunohistochemistry for hematologic neoplasms. Philadelphia: Lippincott Williams & Wilkins. ISBN 978-0-7817-8400-9. OCLC 85862340.
Page 99 in: Sun T (2009). Atlas of hematologic neoplasms. Dordrecht New York: Springer. ISBN 978-0-387-89848-3. OCLC 432709321.

zenodo.org

Naegeli O (1900). «Über rothes Knochenmark und Myeloblasten». Deutsche Medizinische Wochenschrift. 26 (18): 287–290. doi:10.1055/s-0029-1203820.